Back to search
FDAFDA · Food and drugs·Recall number D-0702-2021

Succinylcholine Chloride 100 mg/5 mL (20 mg/mL), 5 mL Syringes, Rx only, For IV Use only, BayCare Central Pharmacy, 7802 E. Telecom Parkway, Temple Terrace, FL 33837

Published August 11, 2021 · Recall initiated: July 30, 2021

Summary

FDA records drug Class II recall D-0702-2021, published August 11, 2021 and initiated July 30, 2021. Recalling firm: BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy; Status: Terminated; Reported quantity: 253 syringes; Lot: Lot: SUCC10020210624 Exp. 09/22/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of sterility assurance

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy
Distributor
FL
Lot
Lot: SUCC10020210624 Exp. 09/22/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Succinylcholine Chloride 100 mg/5 mL (20 mg/mL), 5 mL Syringes, Rx only, For IV Use only, BayCare Central Pharmacy, 7802 E. Telecom Parkway, Temple Terrace, FL 33837 recalled?

Yes. FDA published recall D-0702-2021 on August 11, 2021. Reported hazard: Lack of sterility assurance

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail